DNA X, Inc.
DNA X, Inc. (SONM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SONM · as of Jun 8, 2026
Key Statistics
Explore DNA X, Inc. Data
sonm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
Competitors & Peers
sonm competitorsSONM
BHAT
CLRO
FIEE
GXAI
MITQStock Performance
Full HistoryAbout DNA X, Inc.
DNA X, Inc. formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in deliv…
what is dna x, inc. · sonm stock overview · dna x, inc. company profile · who is dna x, inc. ceo · sonm NASDAQ · dna x, inc. headquarters · dna x, inc. business segments
About Stock Overview & Key Data
DNA X, Inc. (SONM) is a Technology company in the Communication Equipment industry, listed on NASDAQ since May 10, 2019. As of the latest trading session, SONM stock price is $5.14, with a market capitalization of $5.2M. The stock has returned -75.15% over the past 12 months and +59.05% year-to-date.
According to 4 Wall Street analysts, the consensus rating for DNA X, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, DNA X, Inc. reported revenue of — and net income of -$20.7M. For detailed data — including DNA X, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DNA X, Inc. (SONM) stock price is $5.14. The stock is traded on NASDAQ under the ticker symbol SONM. The 52-week range is $2.52 – $38.52.